DewCell Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $15.8M

  • Investors
  • 27

DewCell General Information

Description

Developer of a biotechnology company designed to create artificial platelets using human-derived stem cell-induced differentiation technology and biomimetic technology. The company's system secures differentiation technology from stem cells into megakaryocytes that generate platelets and mass-produces artificial platelets, providing medical researchers with platelets that can solve the shortage of blood-derived platelets.

Contact Information

Website
www.dewcell.com
Formerly Known As
DewCell Biotherapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building A, Room 307, 660 Daewangpangyo-ro
  • Yuspeace 1, Bundang-gu
  • Seongnam, Gyeonggi 13494
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Building A, Room 307, 660 Daewangpangyo-ro
  • Yuspeace 1, Bundang-gu
  • Seongnam, Gyeonggi 13494
  • South Korea
+82

DewCell Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DewCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 29-Mar-2026 $15.8M Completed Generating Revenue
4. Early Stage VC (Series B) 28-Apr-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Jul-2022 Completed Generating Revenue
2. Accelerator/Incubator 03-Apr-2022 $409K $2.35M Completed Generating Revenue
1. Seed Round 30-Nov-2021 $1.94M $1.94M Completed Generating Revenue
To view DewCell’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DewCell Patents

DewCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024205363-A1 Methods for producing red blood cells and platelets Inactive 29-Mar-2023
WO-2024076030-A1 Method for producing platelets Inactive 05-Oct-2022

DewCell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DewCell Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Evergreen Investment Partners Venture Capital Minority
Hanwha Investment & Securities Company Asset Manager Minority
Hyundai Investment Partners Asset Manager Minority
IBK Capital Investment Bank Minority
IBK Venture Investment Corporate Venture Capital Minority
You’re viewing 5 of 27 investors. Get the full list »

DewCell Investments (1)

DewCell’s most recent deal was a Corporate Asset Purchase with DewCell (Quasi-Good Manufacturing Practice Production Facility in Anyang, South Korea). The deal was made on 10-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DewCell (Quasi-Good Manufacturing Practice Production Facility in Anyang, South Korea) 10-Feb-2026 Corporate Asset Purchase Buildings and Property
To view DewCell’s complete investments history, request access »

DewCell FAQs

  • When was DewCell founded?

    DewCell was founded in 2021.

  • Where is DewCell headquartered?

    DewCell is headquartered in Seongnam, South Korea.

  • What is the size of DewCell?

    DewCell has 25 total employees.

  • What industry is DewCell in?

    DewCell’s primary industry is Biotechnology.

  • Is DewCell a private or public company?

    DewCell is a Private company.

  • What is DewCell’s current revenue?

    The current revenue for DewCell is .

  • How much funding has DewCell raised over time?

    DewCell has raised $24.7M.

  • Who are DewCell’s investors?

    Evergreen Investment Partners, Hanwha Investment & Securities Company, Hyundai Investment Partners, IBK Capital, and IBK Venture Investment are 5 of 27 investors who have invested in DewCell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process